• What We Do
    • Investment Banking Services
    • Strategic Advisory & Origination Services
    • Recapitalization Services
  • Our Focus
    • Pharma Services
    • Diagnostics and Tools
    • Healthcare Technology
  • Insights
  • Outcomes
    • Deals
    • Client Testimonials
  • Careers
    • Director Platform
    • Career Development
    • Life at Crosstree
    • Open Positions
  • About
    • About Us
    • Leadership Team
    • Newsroom
    • Events
Connect with us
Connect with us

Our Deals

Connect with Us
Latest Deals
IPeople Acquired by RLDatix, a Portfolio Company of Five Arrows and TA Associates

IPeople Acquired by RLDatix, a Portfolio Company of Five Arrows and TA Associates

Sengenics, a Portfolio Company of Summa Equity, Acquired by Standard BioTools

Sengenics, a Portfolio Company of Summa Equity, Acquired by Standard BioTools

Actigraph, a Portfolio Company of Archimed, Acquired Biofourmis’ Life Science Business

Actigraph, a Portfolio Company of Archimed, Acquired Biofourmis’ Life Science Business

Bio-Techne Divested Assets of Its Subsidiary, Atlanta Biologicals, to GeminiBio

Bio-Techne Divested Assets of Its Subsidiary, Atlanta Biologicals, to GeminiBio

BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering

BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering

Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions

Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions

physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research

physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research

Grant Avenue Capital Recapitalizes CREO

Grant Avenue Capital Recapitalizes CREO

QDx Pathology, a Portfolio Company of Hadley Capital, Acquired by LabGenomics to Expand Esoteric Testing Capabilities Globally

QDx Pathology, a Portfolio Company of Hadley Capital, Acquired by LabGenomics to Expand Esoteric Testing Capabilities Globally

Catalyst Clinical Research, a Portfolio Company of QHP Capital, Acquired Genpro Research to Expand Global Footprint and Deepen Service Offerings

Catalyst Clinical Research, a Portfolio Company of QHP Capital, Acquired Genpro Research to Expand Global Footprint and Deepen Service Offerings

Versiti Acquired Quantigen to Further Expand Clinical Trial Expertise and Service Offering

Versiti Acquired Quantigen to Further Expand Clinical Trial Expertise and Service Offering

Access Medical Labs Allies with Grupo Diagnostico Aries to Expand Diagnostic Lab Capabilities into North America

Access Medical Labs Allies with Grupo Diagnostico Aries to Expand Diagnostic Lab Capabilities into North America

Clinical Site Services and Patient Advertising Guru Acquired by American Clinical Research Services to Add Tech-Enabled Patient Recruitment Capabilities

Clinical Site Services and Patient Advertising Guru Acquired by American Clinical Research Services to Add Tech-Enabled Patient Recruitment Capabilities

Grenova Completes Growth Recapitalization with Peloton Equity to Accelerate Strategic Objectives

Grenova Completes Growth Recapitalization with Peloton Equity to Accelerate Strategic Objectives

PreventionGenetics acquired by Exact Sciences to Enable Earlier Cancer Detection and Hereditary Cancer Testing

PreventionGenetics acquired by Exact Sciences to Enable Earlier Cancer Detection and Hereditary Cancer Testing

Protocol First Joins Flatiron Health® to Help Bridge the Gap Between Real-World Care and Clinical Research

Protocol First Joins Flatiron Health® to Help Bridge the Gap Between Real-World Care and Clinical Research

pharmasol Acquired by PharmaLex to Offer Turnkey End-to-End Pharmacovigilance Solutions

pharmasol Acquired by PharmaLex to Offer Turnkey End-to-End Pharmacovigilance Solutions

UpStream Completes $45 Million Funding Round Led by Dragoneer to Revolutionize Care for Older Adults

UpStream Completes $45 Million Funding Round Led by Dragoneer to Revolutionize Care for Older Adults

Intrinsic Clinical Systems and Pharmica Consulting Acquired by ProPharma Group to Provide Holistic Clinical Trial Execution Expertise

Intrinsic Clinical Systems and Pharmica Consulting Acquired by ProPharma Group to Provide Holistic Clinical Trial Execution Expertise

Pharmica Consulting Acquired by ProPharma Group to Provide Holistic Clinical Trial Execution Expertise

Pharmica Consulting Acquired by ProPharma Group to Provide Holistic Clinical Trial Execution Expertise

View all deals

Sound strategies that
yield superior outcomes

Consult Crosstree
Global Headquarters

5411 Skycenter Drive, Suite 625
Tampa, FL 33607 USA

(813) 774-4750

  • What We Do
    • Investment Banking Services
    • Strategy Advisory & Origination Services
    • Recapitalization Services
  • Our Focus
    • Pharma Services
    • Diagnostics and Tools
    • Healthcare Technology
  • Insights
    • Articles
    • Bluebooks
    • Case Studies
    • Deal Insights
    • Market Maps
    • Videos
    • Whitepapers
  • Outcomes
    • Deals
    • Client Testimonials
  • Careers
    • Director Platform
    • Career Development
    • Life at Crosstree
    • Open Positions
  • About
    • About Us
    • Leadership Team
    • Newsroom
    • Events

All securities transactions are offered by and conducted through Crosstree Capital Securities, LLC, a broker-dealer registered with the SEC, a member of FINRA (www.finra.org) and SIPC (www.sipc.org), and an affiliate of Crosstree Capital Partners Inc.

© 2025 All rights reserved.

Privacy Policy
Business Continuity